(Reuters) - Shares of St Jude Medical Inc (STJ.N) fell 6 percent on Tuesday afternoon after a physician reported to U.S. regulators a failure of the company’s Durata brand lead wire connecting an implanted defibrillator to the heart in a single patient.
The report, posted in a U.S. Food and Drug Administration database, said the lead conductor became externalized, meaning the wire carrying electricity from the defibrillator to the heart was exposed through its insulation.